Furthermore, miR-1294 was downregulated in ovarian cancer (OC) and clear cell renal cell carcinoma (ccRCC), thereby relaxing its repressive effects on insulin-like growth factor 1 receptor (IGF1R) and homeobox A6 (HOXA6). Here, HOXA6 is linked to ovarian carcinoma.